Enlivex Ltd. - Class A common stock (ENLV)

CUSIP: M4130Y106

Q1 2026 13F Holders as of 31 Mar 2026

Holder snapshot 7 signals
Share change
+2,316,531
Put/Call ratio
0%
SEC-reported price per share
$0.93
Number of holders
35
Value change
+$2,203,155
Number of buys
21
Open additional details 1 more signal available
Number of sells
9
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
4,195,190

Security key

M4130Y106

Report period

Q1 2026

Institutions

35

Top holders

10

Ownership snapshot

Top reported holders of ENLV - Enlivex Ltd. - Class A common stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Shai A. Novik
Disclosed value leader
Shai A. Novik
Comparable rows
0/15
Latest evidence
18 Mar 2026
3/4/5 13F Highest disclosed value: $7,252,977 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Shai A. Novik has the largest disclosed position value at $7.25M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Shai A. Novik's linked filing trail.
Disclosed position value Top 5
Shai A. Novik $7.25M
RENAISSANCE TECHNOLOGIES LLC $220.5K
Avraham Havron $191.2K
Oren Hershkovitz $179.8K
Einat Galamidi $162.6K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Shai A. Novik
3/4/5
Director
—
denominator unverified
$7,252,977
6,974,017 shares
— 18 Mar 2026
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
—
denominator unverified
$220,543
313,628 shares
— 31 Dec 2025
Avraham Havron
3/4/5
Director
—
denominator unverified
$191,189
183,836 shares
— 18 Mar 2026
Oren Hershkovitz
3/4/5
Chief Executive Officer
—
denominator unverified
$179,769
172,855 shares
— 18 Mar 2026
Einat Galamidi
3/4/5
Chief Medical Officer
—
denominator unverified
$162,556
156,304 shares
— 18 Mar 2026
Shachar Shlosberger
3/4/5
Chief Financial Officer
—
denominator unverified
$144,886
139,314 shares
— 18 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
35
Shares
3,639,120
Rows available
35
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q1 2026 Across Filers

Q1 2026 holders
35
Q1 2026 holders
35
Holder diff
0
Investor Q1 2026 Shares Q1 2026 Shares Share Diff Share Chg % Q1 2026 value Q1 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .